News Johnson & Johnson

Equities

JNJ

US4781601046

Market Closed - Nyse Other stock markets 04:00:02 2024-05-31 pm EDT			5-day change	1st Jan Change
146.9 ^USD	+1.09%		-0.07%	-6.30%

06:56pm	US lawmakers ask FBI for briefing on GenScript Biotech's links to China	RE
May. 31	Sector Update: Health Care Stocks Higher Late Afternoon	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

US lawmakers ask FBI for briefing on GenScript Biotech's links to China	12:56pm	RE
Sector Update: Health Care Stocks Higher Late Afternoon	May. 31	MT
US lawmakers ask FBI for briefing on GenScript Biotech's links to China	May. 31	RE
Sector Update: Health Care Stocks Advance Friday Afternoon	May. 31	MT
Top Midday Stories: SQM, Codelco to Mine Lithium; Moderna Gets Approval for RSV Vaccine; Tesla Recalls Over 100,000 Cars; Icahn Amasses Stake in Caesars	May. 31	MT
Johnson & Johnson Executive Vice President, William N. Hait, M.D., Ph.D., to Retire, Effective September 2024	May. 31	AQ
J&J: completes acquisition of Shockwave Medical	May. 31	CF
Johnson & Johnson Closes Acquisition of Shockwave Medical	May. 31	MT
Johnson & Johnson Completes Acquisition of Shockwave Medical	May. 31	MT
Johnson & Johnson Completes Acquisition of Shockwave Medical	May. 31	BU
Johnson & Johnson completed the acquisition of Shockwave Medical, Inc. from a group of sellers.	May. 30	CI
Sarepta Therapeutics to Replace Shockwave Medical in S&P MidCap 400	May. 30	MT
Johnson & Johnson : to Participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC) Press Release	May. 29	PU
Transcript : Johnson & Johnson Presents at Bernstein?s 40th Annual Strategic Decisions Conference, May-29-2024 01:30 PM	May. 29
J&J: encouraging results in the treatment of depression	May. 29	CF
Johnson & Johnson's Phase 3 Trial of Seltorexant to Treat Major Depressive Disorder Meets Primary, Secondary Endpoints	May. 29	MT
J&J's treatment for depression succeeds in late stage study	May. 29	RE
Johnson & Johnson Announces Pivotal Study of Seltorexant Shows Statistically Significant and Clinically Meaningful Improvement in Depressive Symptoms and Sleep Disturbance Outcomes	May. 29	CI
NanoViricides (NNVC) Strengthens Drug Development Efforts with Calvert Labs Partnership and Announces Promising RSV Study Results	May. 29	AQ
Sector Update: Health Care Stocks Fall Late Afternoon	May. 28	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

January 23, 2024 at 12:30 pm EST